-
1
-
2
-
3
-
4
-
5
-
6
-
7
-
8
-
9
-
10by Jessica M. Toothaker, Pietro Presicce, Monica Cappelletti, Stephanie F. Stras, Stephanie F. Stras, Collin C. McCourt, Collin C. McCourt, Claire A. Chougnet, Suhas G. Kallapur, Liza Konnikova, Liza Konnikova, Liza Konnikova, Liza KonnikovaGet full text
Published 2020-05-01
Article -
11
-
12
-
13
-
14by Collin C. Luk, Abdullah Ishaque, Muhammad Khan, Daniel Ta, Sneha Chenji, Yee‐Hong Yang, Dean Eurich, Sanjay Kalra, the Alzheimer's Disease Neuroimaging InitiativeGet full text
Published 2018-01-01
Article -
15by Collin C. Barber MD, Teresa Hall, Tyler Madden, Parin D. Kothari, Monica LaPointe, John G. Anderson MD, Donald R. Bohay MD, FACS, John D. Maskill MD, Michelle A. Padley MSGet full text
Published 2020-10-01
Article -
16by Yujia Li, Jessica M. Toothaker, Shira Ben-Simon, Lital Ozeri, Ron Schweitzer, Blake T. McCourt, Collin C. McCourt, Lael Werner, Scott B. Snapper, Dror S. Shouval, Soliman Khatib, Omry Koren, Sameer Agnihorti, George Tseng, Liza KonnikovaGet full text
Published 2020-11-01
Article -
17by Christophe ePy, Marzia eMartina, Gerardo A Diaz-Quijada, Collin C Luk, Dolores eMartinez, Mike W Denhoff, Anne eCharrier, Tanya eComas, Robert eMonette, Anthony eKrantis, Naweed I Syed, Geoffrey A.R. MealingGet full text
Published 2011-10-01
Article -
18The novel BET‐CBP/p300 dual inhibitor NEO2734 is active in SPOP mutant and wild‐type prostate cancerby Yuqian Yan, Jian Ma, Dejie Wang, Dong Lin, Xiaodong Pang, Shangqian Wang, Yu Zhao, Lei Shi, Hui Xue, Yunqian Pan, Jun Zhang, Claes Wahlestedt, Francis J Giles, Yu Chen, Martin E Gleave, Collin C Collins, Dingwei Ye, Yuzhuo Wang, Haojie HuangGet full text
Published 2019-11-01
Article -
19by Lisa A McConnachie, Dianne Botta, Collin C White, Chad S Weldy, Hui-Wen Wilkerson, Jianbo Yu, Russell Dills, Xiaozhong Yu, William C Griffith, Elaine M Faustman, Federico M Farin, Sean E Gill, William C Parks, Xiaoge Hu, Xiaohu Gao, David L Eaton, Terrance J KavanaghGet full text
Published 2013-01-01
Article